Clinical Trial Update: Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating prevention of skin cancer in high-risk patients after conversion to a sirolimus-based immunosuppressive protocol was terminated. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Cancer

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Skin Cancer | Phase 4 | Status: TERMINATED | Results posted: 2025-03-14